论文部分内容阅读
BXT51072通用名:BXT51072研发进展:II期临床研发公司:美国O X I S Therapeutics公司作用机理:谷胱甘肽过氧化物酶拟似物适应症:溃疡性结肠炎简介:B X T51072是一个硒类衍生物,为口服活性谷胱甘肽过氧化物酶拟似物,可抑制NF-kappaB,促进过氧化物代谢,预防氧化损害和降低炎性反应
BXT51072 Common Name: BXT51072 Development: Phase II Clinical Development Company: OXIS Therapeutics, USA Mechanism of Action: Glutathione Peroxidase Mimetics Indications: Ulcerative Colitis Description: BX T51072 is a selenium derivative, Is an orally active glutathione peroxidase analog that inhibits NF-kappaB, promotes peroxide metabolism, prevents oxidative damage and reduces inflammatory responses